Neurobiologia de La Conciencia
Neurobiologia de La Conciencia
Neurobiologia de La Conciencia
N e u ro b i o l o g y a n d
the Major Classes
of Impairment
a,b, a
Andrew M. Goldfine, MD *, Nicholas D. Schiff, MD
KEYWORDS
Consciousness Vegetative state Minimally conscious state
Traumatic brain injury Arousal
This work was supported by NIH-NICHD 51912, the James S McDonnell Foundation. AMG is
supported by grant KL2RR024997 of the Clinical & Translational Science Center at Weill Cornell
Medical College.
a
Department of Neurology and Neuroscience, Weill Cornell Medical College, LC 803, 1300
York Avenue, New York, NY 10065, USA
b
Burke Medical Research Institute, Weill Cornell Medical College, 785 Mamaroneck Avenue,
White Plains, NY 10605, USA
* Corresponding author. Burke Medical Research Institute, Weill Cornell Medical College, 785
Mamaroneck Avenue, White Plains, NY 10605.
E-mail address: [email protected]
The disorders of consciousness discussed in this article are syndromes that are behav-
iorally defined, and each is thought to reflect a specific pathophysiologic model
(Table 1). However, the models are imprecise and do not apply in every case. As
such, we will begin with an overview of the behavioral assessment of levels of conscious-
ness, followed by more detailed descriptions for each syndrome. Pathology and imaging
data are used to support mechanistic models underlying each behavioral syndrome.
Fig. 1. A network that drives goal-directed behavior together with targets for specific inter-
ventions. ACC, anterior cingulate cortex; GPi, globus pallidus pars interna; ILN, intralaminar
nuclei of the thalamus; MSN, medium spiny neurons; PFC, prefrontal cortex. Blue arrows repre-
sent glutamatergic synapses and red represents GABAergic synapses unless otherwise noted.
726 Goldfine & Schiff
Table 1
Summary of behavioral features and pathophysiologies of disorders of consciousness
syndromes from permanent brain injury
auditory) and cognitive domains (eg, language and learned movements). The lowest
level of behavior to be documented is whether eye opening is spontaneous or requires
stimulation (eg, loud sounds or noxious touch). Higher-level behaviors include
responses that are contingent on sensory stimuli. These range from eyes tracking
a mirror and withdrawal from painful touch, to accurately following commands and
the use of objects (eg, a comb or toothbrush).21 The level of effort required to alert
the patient and the speed of their response should also be noted, because these
observations guide subjective and objective assessments of arousal. Inaccuracy in
specific cognitive domains (eg, aphasia and apraxia) reflects focal impairments in
awareness, rather than global disorders of consciousness.
One caveat to behavioral testing of arousal is that all of the patient responses require
a capacity for motor output and adequate arousal. Patients with functional or struc-
tural interruption of motor systems at any level may not be able to follow the
commands, despite full comprehension and intention. Patients with a minimal residual
ability to communicate (eg, eye blinks) but who have generally intact consciousness,
Neurobiology of Consciousness 727
are deemed to be in the locked-in state (LIS).1 There are also patients with both
impaired motor output and arousal from diffuse brain injury, which contribute to
a high misdiagnosis rate in disorders of consciousness.22,23 To ensure accurate diag-
nosis in patients with diffuse brain injury, it is essential to examine patients at maximal
levels of arousal using techniques such as deep tendon massage or postural reposi-
tioning.24 Patients should also be examined at multiple time points or videotaped by
family to capture periods of high alertness.
In vivo imaging studies further support the model of VS that represents diffuse cortico-
thalamic dysfunction. Fluorodeoxyglucose (FDG)-positron emission tomography (PET)
is a measure of energy consumption, and in the brain it primarily represents the neuronal
firing rate at the synapse.34 Patients in PVS have been shown to have global metabolic
rates reduced by 50% or more compared to healthy controls.35 In general, metabolic
rates exhibit less reduction in the brainstem and more reduction in the cortex and
subcortical nuclei, with the most consistent reduction occurring in the medial parietal
and frontal areas.36 Comparable reductions in cerebral metabolic rate have been iden-
tified during generalized anesthesia37,38 and slow-wave sleep in healthy controls.39,40
To examine corticothalamic functioning more directly, investigators have used
H215O-PET, functional magnetic resonance imaging (fMRI), and event-related poten-
tial analysis to measure brain responses to sensory inputs.41 Studies using simple and
complex auditory stimuli42–44 and noxious stimuli45 have demonstrated a pattern of
activation of brainstem and primary sensory cortical regions in some patients with
VS without the activation of higher-order sensory or association areas. These results
suggest that patients with VS may have some residual thalamocortical activity, but do
not possess enough to produce the global integrative function that is required for
conscious awareness.
These imaging tools have also been used to provide insight into an ambiguous area
between VS and consciousness. Schiff and colleagues46 described 3 patients who
demonstrated complex motor behaviors but were still considered to be in VS. All were
found to have an overall low resting metabolism (20–50% of normal by FDG-PET), yet
had residual islands of cortical and subcortical higher metabolism in areas consistent
with their behaviors. In all patients, these brain structures showed marked abnormalities
at the level of response to simple sensory stimuli as measured by magnetoencephalog-
raphy, which demonstrated a loss of the integrity of even early cortical processing. These
patients, similar to those studied by Laureys and colleagues,44,47 revealed that some
preservation of basic corticothalamic processing may coexist with behavioral uncon-
sciousness and this does not contravene a clinical diagnosis of VS.
that across the continuum of VS to MCS to full consciousness, patients were less likely
to have severe DAI and more likely to have focal brain injuries, such as hematomas
and contusions.53 Notably, these investigators reported overlap in pathologic find-
ings across all levels of consciousness, which demonstrated that current anatomic
methods cannot completely account for the variances in behavior.
Functional imaging (fMRI and H215O-PET) and neurophysiologic methods have
proved to be more sensitive than anatomic methods in distinguishing patients in VS
from those in MCS, because they measure corticothalamic function. For example,
when presented with sensory stimuli, MCS patients activate higher-order association
cortices, similar to healthy controls, whereas VS patients, at best, activate primary
sensory cortices.55,56 However, compared to healthy controls, MCS patients require
a higher level of arousal (ie, more alerting stimuli) to produce similar patterns of acti-
vation.42 This requirement for a higher level of arousal is consistent with behavioral
data, which show that these patients fluctuate in their level of responsiveness57 and
suggest an underlying inability to maintain cerebral integrative functioning.
Fig. 2. Noninvasive imaging evidence of command following in a patient with severe brain
injury who was behaviorally locked in. (A) fMRI demonstrating increased activity (orange) in
supplementary motor and other cortical areas when the patient was asked to imagine swim-
ming versus a resting baseline. (B) Spectral analysis of EEG in the same patient performing
the imagination of the swimming task at a different time. Example power spectra for 2 channels
are on the right; the image on the left summarizes significant spectral changes across all chan-
nels and frequencies tested. Head maps below summarize amplitude of power change across all
channels at the frequencies listed directly above. (Adapted from Bardin JC, Fins JJ, Katz DI, et al.
Dissociations between behavioural and functional magnetic resonance imaging-based evalu-
ations of cognitive function after brain injury. Brain 2011;134(Pt 3):769–82; Goldfine AM,
Victor JD, Conte MM, et al. Determination of awareness in patients with severe brain injury
using EEG power spectral analysis. Clin Neurophysiol 2011. Available at: http://www.ncbi.
nlm.nih.gov/pubmed/21514214. Accessed July 17, 2011; with permission.)
732 Goldfine & Schiff
Akinetic mutism offers a model for approaches that improve the level of conscious-
ness (see Fig. 1). In akinetic mutism, the injury to the cortico-striatopallidal-
thalamocortical circuit involving the medial frontal lobe can produce dysfunction as
severe as in patients with much more widespread injury.58,61 Increasing the function
of this circuit through medication or brain electrical stimulation can drive activity widely
through the cerebrum.80 For example, dopaminergic agents (eg, amantadine, levo-
dopa, bromocriptine, or apomorphine) that enhance striatal background activity,
have been shown to raise the level of consciousness and improve recovery rates in
patients with various severe brain injuries (reviewed by Hirschberg and Giacino else-
where in this issue). Zolpidem, an agonist of a subset of g-aminobutyric acid(A)
(GABAA) receptors, has also been demonstrated to dramatically improve conscious-
ness in patients with diffuse brain injury.81,82 The mechanism of action of zolpidem
is thought to occur through cortical activation, both directly83 and indirectly, by inhib-
iting the globus pallidus interna from inhibiting thalamocortical firing.84 Another
successful approach through the same network, although only reported in a single
patient, is direct activation central thalamic outflow via deep brain stimulation
(DBS).85,86
There are no clear guidelines for medical management to attempt to speed recovery
of consciousness, as almost all data are from case series. Accordingly, we offer some
approaches that have been proved to be successful in our experience. For a medically
stable patient with a disorder of consciousness, the first goal is to rule out potential
inhibitors of recovery. This includes undiagnosed seizure disorders, particularly
because they can be difficult to detect behaviorally in patients with impaired motor
output. Medications can also be culprits in worsening arousal, especially those with
anticholinergic, antihistaminergic, barbiturate, and benzodiazepine properties as
well as some antiepileptic and antispasticity agents.87
To promote recovery of consciousness, we recommend amantadine 200–400 mg,
split between early morning and early afternoon doses. Amantadine has a relatively
benign safety profile and is the only medication tested to date in patients in VS and
MCS in a well-powered, randomized, double-blind, clinical trial,88 although the
results have not yet been published. A selective serotonin reuptake inhibitor may
also be added, based on animal model89 and clinical trial90 evidence for enhancing
plasticity, although there is no strong evidence in patients with disorders of
consciousness. Zolpidem can be given as 5 or 10 mg doses with a response
expected within 1 hour, though only rarely.91 Zolpidem is apparently safe, though
there are no long-term data and the potential for habituation exists. Medications
should be trialed individually, with a gradual titration of doses. Patients should
have well-documented formal examinations using the CRS-R before and after initi-
ation and dose changes, and any side effects should be noted. In addition, physical,
occupational, and speech therapy should be used when appropriate, including daily
joint stretching to avoid contractures, which can severely limit movement when the
motor system recovers.
Neurobiology of Consciousness 733
SUMMARY
Fins92 has argued against a nihilistic approach to patients with chronic disorders of
consciousness, as if the loss of function is invariably permanent and there is nothing
more to be gained from diagnostic testing and treatment. We agree that these patients
deserve a more systematic approach to assessment, prognosis, and treatment. The
evidence described in this review shows that these conditions include a wide range
of pathologies, causes, prognoses, and proven treatments. Diagnostic testing can
be used to determine the degree of injury and suggest residual capacity for cognitive
function. Future work will allow the use of imaging modalities to predict recovery and
development of tools to communicate with those who have lost all motor function.
REFERENCES
1. Posner JB, Saper CB, Schiff ND, et al. Plum and Posner’s diagnosis of stupor and
coma. 4th edition. New York: Oxford University Press; 2007.
2. Steriade MM, McCarley RW. Brain control of wakefulness and sleep. 2nd edition.
New York (NY): Kluwer Academic/Plenum Publishers; 2005.
3. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG.
Electroencephalogr Clin Neurophysiol 1949;1(4):455–73.
4. Magoun HW. The waking brain. Springfield (IL): Charles C Thomas; 1958.
5. Parvizi J, Damasio A. Consciousness and the brainstem. Cognition 2001;79(1–2):
135–60.
6. Steriade M, Glenn LL. Neocortical and caudate projections of intralaminar
thalamic neurons and their synaptic excitation from midbrain reticular core.
J Neurophysiol 1982;48(2):352–71.
7. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging thera-
peutic targets for sleep disorders. Nat Neurosci 2002;5(Suppl):1071–5.
8. Llinás R, Ribary U, Contreras D, et al. The neuronal basis for consciousness.
Philos Trans R Soc Lond B Biol Sci 1998;353(1377):1841–9.
9. Jones EG. Thalamic circuitry and thalamocortical synchrony. Philos Trans R Soc
Lond B Biol Sci 2002;357(1428):1659–73.
10. Tononi G, Edelman GM. Consciousness and complexity. Science 1998;282
(5395):1846–51.
11. Broadbent DE. Perception and communication. London (UK): Pergamon Press;
1958.
12. Garey J, Goodwillie A, Frohlich J, et al. Genetic contributions to generalized
arousal of brain and behavior. Proc Natl Acad Sci U S A 2003;100(19):11019–22.
13. Pfaff D. Brain arousal and information theory: neural and genetic mechanisms.
1st edition. Cambridge (MA): Harvard University Press; 2005.
14. Searle JR. Intentionality, an essay in the philosophy of mind. Cambridge (UK):
Cambridge University Press; 1983.
15. Brentano F. Psychology from an empirical standpoint. 2nd edition. New York (NY):
Routledge; 1995.
16. Frith CD, Friston K, Liddle PF, et al. Willed action and the prefrontal cortex in man:
a study with PET. Proc Biol Sci 1991;244(1311):241–6.
17. Paus T, Koski L, Caramanos Z, et al. Regional differences in the effects of task
difficulty and motor output on blood flow response in the human anterior cingulate
cortex: a review of 107 PET activation studies. Neuroreport 1998;9(9):R37–47.
18. Paus T, Zatorre RJ, Hofle N, et al. Time-related changes in neural systems under-
lying attention and arousal during the performance of an auditory vigilance task.
J Cogn Neurosci 1997;9(3):392–408.
734 Goldfine & Schiff
39. Maquet P, Dive D, Salmon E, et al. Cerebral glucose utilization during sleep-wake
cycle in man determined by positron emission tomography and [18F]2-fluoro-2-
deoxy-D-glucose method. Brain Res 1990;513(1):136–43.
40. Maquet P, Degueldre C, Delfiore G, et al. Functional neuroanatomy of human slow
wave sleep. J Neurosci 1997;17(8):2807–12.
41. Cruse D, Owen AM. Consciousness revealed: new insights into the vegetative
and minimally conscious states. Curr Opin Neurol 2010;23(6):656–60.
42. Schiff ND, Rodriguez-Moreno D, Kamal A, et al. fMRI reveals large-scale network
activation in minimally conscious patients. Neurology 2005;64(3):514–23.
43. Bekinschtein TA, Dehaene S, Rohaut B, et al. Neural signature of the conscious
processing of auditory regularities. Proc Natl Acad Sci U S A 2009;106(5):
1672–7.
44. Laureys S, Faymonville M-E, Degueldre C, et al. Auditory processing in the vege-
tative state. Brain 2000;123(8):1589–601.
45. Laureys S, Faymonville ME, Peigneux P, et al. Cortical processing of noxious
somatosensory stimuli in the persistent vegetative state. Neuroimage 2002;
17(2):732–41.
46. Schiff ND, Ribary U, Moreno DR, et al. Residual cerebral activity and behavioral
fragments can remain in the persistently vegetative brain. Brain 2002;125(6):
1210–34.
47. Laureys S, Lemaire C, Maquet P, et al. Cerebral metabolism during vegetative
state and after recovery to consciousness. J Neurol Neurosurg Psychiatry
1999;67(1):121–2.
48. Giacino JT, Ashwal S, Childs N, et al. The minimally conscious state: definition
and diagnostic criteria. Neurology 2002;58(3):349–53.
49. Andrews K, Murphy L, Munday R, et al. Misdiagnosis of the vegetative state:
retrospective study in a rehabilitation unit. BMJ 1996;313(7048):13–6.
50. Vanhaudenhuyse A, Schnakers C, Brédart S, et al. Assessment of visual pursuit
in post-comatose states: use a mirror. J Neurol Neurosurg Psychiatry 2008;79(2):
223.
51. Estraneo A, Moretta P, Loreto V, et al. Late recovery after traumatic, anoxic, or
hemorrhagic long-lasting vegetative state. Neurology 2010;75(3):239–45.
52. Luauté J, Maucort-Boulch D, Tell L, et al. Long-term outcomes of chronic mini-
mally conscious and vegetative states. Neurology 2010;75(3):246–52.
53. Jennett B, Adams JH, Murray LS, et al. Neuropathology in vegetative and
severely disabled patients after head injury. Neurology 2001;56(4):486–90.
54. Kampfl A, Schmutzhard E, Franz G, et al. Prediction of recovery from post-
traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet
1998;351(9118):1763–7.
55. Boly M, Faymonville ME, Peigneux P, et al. Auditory processing in severely brain
injured patients: differences between the minimally conscious state and the
persistent vegetative state. Arch Neurol 2004;61(2):233–8.
56. Bekinschtein T, Niklison J, Sigman L, et al. Emotion processing in the minimally
conscious state. J Neurol Neurosurg Psychiatry 2004;75(5):788.
57. Hart T, Whyte J, Millis S, et al. Dimensions of disordered attention in traumatic
brain injury: further validation of the moss attention rating scale. Arch Phys
Med Rehabil 2006;87(5):647–55.
58. Cairns H, Oldfield RC, Pennybacker JB, et al. Akinetic mutism with an epidermoid
cyst of the 3rd ventricle. Brain 1941;64(4):273–90.
59. Fisher CM. Honored guest presentation: abulia minor vs. agitated behavior. Clin
Neurosurg 1983;31:9–31.
736 Goldfine & Schiff
60. Stuss DT, Alexander MP. Is there a dysexecutive syndrome? Philos Trans R Soc
Lond B Biol Sci 2007;362(1481):901–15.
61. Schiff ND, Plum F. The role of arousal and “gating” systems in the neurology of
impaired consciousness. J Clin Neurophysiol 2000;17(5):438–52.
62. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal
lesions of the basal ganglia in man. Brain 1994;117(4):859–76.
63. Mega MS, Cohenour RC. Akinetic mutism: disconnection of frontal-subcortical
circuits. Neuropsychiatry Neuropsychol Behav Neurol 1997;10(4):254–9.
64. Segarra JM. Cerebral vascular disease and behavior: the syndrome of the
mesencephalic artery (basilar artery bifurcation). Arch Neurol 1970;22(5):
408–18.
65. Owen AM, Coleman MR, Boly M, et al. Detecting awareness in the vegetative
state. Science 2006;313(5792):1402.
66. Monti MM, Vanhaudenhuyse A, Coleman MR, et al. Willful modulation of brain
activity in disorders of consciousness. N Engl J Med 2010;362(7):579–89.
67. Bardin JC, Fins JJ, Katz DI, et al. Dissociations between behavioural and func-
tional magnetic resonance imaging-based evaluations of cognitive function after
brain injury. Brain 2011;134(Pt 3):769–82.
68. Goldfine AM, Victor JD, Conte MM, et al. Determination of awareness in patients
with severe brain injury using EEG power spectral analysis. Clin Neurophysiol
2011. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21514214. Accessed
July 17, 2011.
69. Jennett B. The vegetative state: medical facts, ethical and legal dilemmas.
Cambridge (UK): Cambridge University Press; 2002.
70. Levy DE, Caronna JJ, Singer BH, et al. Predicting outcome from hypoxic-
ischemic coma. JAMA 1985;253(10):1420–6.
71. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-
hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346(8):
557–63.
72. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia
to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;
346(8):549–56.
73. Rossetti AO, Oddo M, Logroscino G, et al. Prognostication after cardiac
arrest and hypothermia: a prospective study. Ann Neurol 2010;67(3):
301–7.
74. Voss HU, Uluç AM, Dyke JP, et al. Possible axonal regrowth in late recovery from
the minimally conscious state. J Clin Invest 2006;116(7):2005–11.
75. Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after
traumatic brain injury. J Head Trauma Rehabil 2005;20(1):76–94.
76. Bendlin BB, Ries ML, Lazar M, et al. Longitudinal changes in patients with trau-
matic brain injury assessed with diffusion-tensor and volumetric imaging. Neuro-
image 2008;42(2):503–14.
77. Sidaros A, Engberg AW, Sidaros K, et al. Diffusion tensor imaging during
recovery from severe traumatic brain injury and relation to clinical outcome:
a longitudinal study. Brain 2008;131(2):559–72.
78. Dancause N, Barbay S, Frost SB, et al. Extensive cortical rewiring after brain
injury. J Neurosci 2005;25(44):10167–79.
79. Katz DI, Alexander MP, Mandell AM. Dementia following strokes in the mesen-
cephalon and diencephalon. Arch Neurol 1987;44(11):1127–33.
80. Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypoth-
esis. Trends Neurosci 2010;33(1):1–9.
Neurobiology of Consciousness 737
81. Clauss RP, van der Merwe CE, Nel HW. Arousal from a semi-comatose state on
zolpidem. S Afr Med J 2001;91(10):788–9.
82. Brefel-Courbon C, Payoux P, Ory F, et al. Clinical and imaging evidence of zolpi-
dem effect in hypoxic encephalopathy. Ann Neurol 2007;62(1):102–5.
83. McCarthy MM, Brown EN, Kopell N. Potential network mechanisms mediating
electroencephalographic beta rhythm changes during propofol-induced para-
doxical excitation. J Neurosci 2008;28(50):13488–504.
84. Schiff ND, Posner JB. Another “Awakenings.” Ann Neurol 2007;62(1):5–7.
85. Schiff ND, Giacino JT, Kalmar K, et al. Behavioural improvements with thalamic
stimulation after severe traumatic brain injury. Nature 2007;448(7153):600–3.
86. Schiff ND. Central thalamic deep-brain stimulation in the severely injured brain:
rationale and proposed mechanisms of action. Ann N Y Acad Sci 2009;1157:
101–16.
87. Goldstein LB. Common drugs may influence motor recovery after stroke. The Sy-
gen In Acute Stroke Study Investigators. Neurology 1995;45(5):865–71.
88. Meythaler JM, Brunner RC, Johnson A, et al. Amantadine to improve neuro-
recovery in traumatic brain injury-associated diffuse axonal injury: a pilot
double-blind randomized trial. J Head Trauma Rehabil 2002;17(4):300–13.
89. Vetencourt JFM, Sale A, Viegi A, et al. The antidepressant fluoxetine restores
plasticity in the adult visual cortex. Science 2008;320(5874):385–8.
90. Chollet F, Tardy J, Albucher J-F, et al. Fluoxetine for motor recovery after acute
ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol
2011;10(2):123–30.
91. Whyte J, Myers R. Incidence of clinically significant responses to zolpidem
among patients with disorders of consciousness: a preliminary placebo con-
trolled trial. Am J Phys Med Rehabil 2009;88(5):410–8.
92. Fins JJ. Constructing an ethical stereotaxy for severe brain injury: balancing risks,
benefits and access. Nat Rev Neurosci 2003;4(4):323–7.